{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:11:05Z","timestamp":1785168665499,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.aohep.2021.100547","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T23:57:13Z","timestamp":1633651033000},"page":"100547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Safety and efficacy of human serum albumin treatment in patients with cirrhotic ascites undergoing paracentesis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"26","author":[{"given":"Dhan Bahadur","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravash","family":"Budhathoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yub Raj","family":"Sedhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramkaji","family":"Baniya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shila","family":"Awal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jashpal","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lila","family":"Awal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markos G.","family":"Kashiouris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey A.","family":"Cable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2021.100547_bib0001","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2021.100547_bib0002","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0016-5085(88)90691-9","article-title":"Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis","volume":"94","author":"Gin\u00e8s","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2021.100547_bib0003","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1440-1746.2005.03982.x","article-title":"Spontaneous bacterial peritonitis in cirrhotic patients: is prophylactic propranolol therapy beneficial?","volume":"21","author":"Cholongitas","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2021.100547_bib0004","doi-asserted-by":"crossref","DOI":"10.1136\/gut.2006.099580","article-title":"Guidelines on the management of ascites in cirrhosis","volume":"55","author":"Moore","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2021.100547_bib0005","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0168-8278(98)80288-2","article-title":"Hemodynamic changes in patients developing effective hypovolemia after total paracentesis","volume":"28","author":"Vila","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2021.100547_bib0006","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1478-3231.2008.01734.x","article-title":"Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study","volume":"28","author":"Appenrodt","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2021.100547_bib0007","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1097\/MEG.0000000000000548","article-title":"The clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations","volume":"28","author":"Pericleous","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2021.100547_bib0008","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep.26359","article-title":"Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012","volume":"57","author":"Runyon","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2021.100547_bib0009","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/jgh.13421","article-title":"Insufficient evidence of benefit regarding mortality due to albumin substitution in HCC-free cirrhotic patients undergoing large volume paracentesis","volume":"32","author":"K\u00fctting","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2021.100547_bib0010","article-title":"Comparing the effects of hydroxyethyl starch and albumin in cirrhotic patients with tense ascites; a randomized clinical trial","volume":"1","author":"Abootalebi","year":"2017","journal-title":"Adv J Emerg Med"},{"key":"10.1016\/j.aohep.2021.100547_bib0011","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MEG.0000000000001277","article-title":"Oral midodrine is comparable to albumin infusion in cirrhotic patients with refractory ascites undergoing large-volume paracentesis","volume":"31","author":"Yosry","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2021.100547_bib0012","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.aohep.2021.100547_bib0013","unstructured":"Shrestha D, Budhathoki P, Sedhai YR, Awal S, Yadav J, Awal L, et\u00a0al. A meta-analysis of efficacy and safety of human serum albumin treatment in patients with ascites due to cirrhosis. PROSPERO 2020 CRD42020223464 n.d. https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=223464 (accessed May 27, 2021 )."},{"key":"10.1016\/j.aohep.2021.100547_bib0014","unstructured":"How can I cite Covidence? n.d. https:\/\/support.covidence.org\/help\/how-can-i-cite-covidence (accessed January 26, 2021 )."},{"key":"10.1016\/j.aohep.2021.100547_bib0015","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.aohep.2021.100547_bib0016","unstructured":"9.5.2 Identifying and measuring heterogeneity n.d. https:\/\/handbook-5-1.cochrane.org\/chapter_9\/9_5_2_identifying_and_measuring_heterogeneity.htm (accessed December 18, 2020)."},{"key":"10.1016\/j.aohep.2021.100547_bib0017","unstructured":"RevMan for non-Cochrane reviews | Cochrane Training n.d. https:\/\/training.cochrane.org\/online-learning\/core-software-cochrane-reviews\/revman\/revman-non-cochrane-reviews (accessed January 26, 2021)."},{"key":"10.1016\/j.aohep.2021.100547_bib0018","unstructured":"Mean Variance Estimation n.d. https:\/\/web.archive.org\/web\/20181224162602\/http:\/www.comp.hkbu.edu.hk\/\u223cxwan\/median2mean.html (accessed December 19, 2020)."},{"key":"10.1016\/j.aohep.2021.100547_bib0019","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ajg.2010.01.006","article-title":"Randomized trial comparing human albumin and hydroxyethyl starch 6% as plasma expanders for treatment of patients with liver cirrhosis and tense ascites following large volume paracentesis","volume":"11","author":"Abdel-Khalek","year":"2010","journal-title":"Arab J Gastroenterol"},{"key":"10.1016\/j.aohep.2021.100547_bib0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00042737-199801000-00002","article-title":"Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis","volume":"10","author":"Altman","year":"1998","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2021.100547_bib0021","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.cgh.2012.06.027","article-title":"The combination of octreotide and midodrine is not superior to albumin in preventing recurrence of ascites after large-volume paracentesis","volume":"10","author":"Bari","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2021.100547_bib0022","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0168-8278(92)90176-P","article-title":"Paracentesis with Dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites. Results of a randomized study","volume":"14","author":"Fassio","year":"1992","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2021.100547_bib0023","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1600-0676.1993.tb00637.x","article-title":"Total therapeutic paracentesis (TTP) with and without intravenous albumin in the treatment of cirrhotic tense ascites: a randomized controlled trial","volume":"13","author":"Garcia-Compe\u00e1n","year":"1993","journal-title":"Liver"},{"key":"10.1016\/j.aohep.2021.100547_bib0024","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1665-2681(19)32189-1","article-title":"Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial","volume":"1","author":"Garc\u00eda-Compean","year":"2002","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.aohep.2021.100547_bib0025","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0016-5085(96)70068-9","article-title":"Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis","volume":"111","author":"Gines","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2021.100547_bib0026","unstructured":"Rahim UR, Latif M. Hemaccel as a Cheaper Alternative to Human Albumin for Plasma Expansion during Paracentesis in Cirrhotic patients. n.d."},{"key":"10.1016\/j.aohep.2021.100547_bib0027","first-page":"753","article-title":"Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis","volume":"22","author":"Luca","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2021.100547_bib0028","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/gut.50.1.90","article-title":"Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study","volume":"50","author":"Moreau","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2021.100547_bib0029","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1478-3231.2005.01188.x","article-title":"Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trial","volume":"26","author":"Moreau","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2021.100547_bib0030","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/0016-5085(90)90481-F","article-title":"Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study","volume":"99","author":"Planas","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2021.100547_bib0031","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0168-8278(87)80067-3","article-title":"Repeated paracentesis and i.v. albumin infusion to treat \u201ctense\u201d ascites in cirrhotic patients. A safe alternative therapy","volume":"5","author":"Salerno","year":"1987","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2021.100547_bib0032","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.1840130416","article-title":"Randomized comparative study of hemaccel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites","volume":"13","author":"Salerno","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2021.100547_bib0033","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/j.1572-0241.2008.01787.x","article-title":"Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study","volume":"103","author":"Singh","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aohep.2021.100547_bib0034","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1440-1746.2006.04182.x","article-title":"Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study","volume":"21","author":"Singh","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2021.100547_bib0035","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1053\/jhep.2003.50169","article-title":"Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites","volume":"37","author":"Sola-Vera","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2021.100547_bib0036","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/hep.24786","article-title":"Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials","volume":"55","author":"Bernardi","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2021.100547_bib0037","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list","volume":"359","author":"Kim","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aohep.2021.100547_bib0038","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1478-3231.2010.02293.x","article-title":"Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration","volume":"30","author":"Guevara","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2021.100547_bib0039","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aohep.2021.100547_bib0040","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial","volume":"391","author":"Caraceni","year":"2018","journal-title":"Lancet"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268121002465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268121002465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:44:11Z","timestamp":1761648251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268121002465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":40,"alternative-id":["S1665268121002465"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2021.100547","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of human serum albumin treatment in patients with cirrhotic ascites undergoing paracentesis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2021.100547","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100547"}}